Poland vs Spain: Cause of death, by non-communicable diseases, ages 0-4, female
Poland
43.9%
in 2021
Spain
43.8%
in 2021
Poland rank
26th
Spain rank
27th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Poland
- Spain
How they compare
Poland currently reports 43.9% against 43.8% in Spain, a difference of 0.1%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Spain ahead.
Poland ranks 26th and Spain ranks 27th of 185 countries.
Across the 3 decades both report, Poland averaged higher in 2 and Spain in 1.
Head to head by decade
| Decade | Poland | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 46.4% | 1.9% | Spain |
| 2010s | 44.2% | 43.6% | 0.7% | Poland |
| 2020s | 43.5% | 43.0% | 0.5% | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Poland or Spain?
- Poland, at 43.9% against 43.8% in Spain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Poland and Spain?
- 0.1%, with Poland ahead.
- How many years of comparable data are there for Poland and Spain?
- 6 years are reported by both, from 2000 to 2021.
- How do Poland and Spain rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Poland ranks 26th and Spain ranks 27th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.